{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:26Z","timestamp":1792785026689,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Italian Ministry of University and Research","award":["PRIN 2020, code 20209TB4AX"],"award-info":[{"award-number":["PRIN 2020, code 20209TB4AX"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30970-x","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:47:44Z","timestamp":1767869264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum HDL subfractions are impaired by COVID-19 vaccine in patients with thymic epithelial tumors"],"prefix":"10.1038","volume":"16","author":[{"given":"Gustavo","family":"Cernera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"De Placido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Pietroluongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovannella","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gelzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"30970_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","volume":"595","author":"U Sahin","year":"2021","unstructured":"Sahin, U. et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature 595, 572\u2013577 (2021).","journal-title":"Nature"},{"key":"30970_CR2","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","volume":"397","author":"EJ Haas","year":"2021","unstructured":"Haas, E. J. et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data. Lancet 397, 1819\u20131829 (2021).","journal-title":"Lancet"},{"key":"30970_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779453","volume":"12","author":"SR Ostrowski","year":"2021","unstructured":"Ostrowski, S. R. et al. Inflammation and platelet activation after COVID-19 vaccines\u2014Possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis. Front. Immunol. 12, 779453 (2021).","journal-title":"Front. Immunol."},{"key":"30970_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jtho.2021.10.010","volume":"17","author":"A Marx","year":"2022","unstructured":"Marx, A. et al. The 2021 WHO classification of tumors of the thymus and mediastinum: What is new in thymic epithelial, germ cell, and mesenchymal tumors?. J. Thorac. Oncol. 17, 200\u2013213 (2022).","journal-title":"J. Thorac. Oncol."},{"key":"30970_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.908453","volume":"13","author":"AM Malfitano","year":"2022","unstructured":"Malfitano, A. M. et al. Immunological signature of patients with thymic epithelial tumors and good syndrome. Front. Immunol. 13, 908453 (2022).","journal-title":"Front. Immunol."},{"key":"30970_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21037\/med.2019.08.02","volume":"3","author":"C Zhao","year":"2019","unstructured":"Zhao, C. & Rajan, A. Immune checkpoint inhibitors for treatment of thymic epithelial tumors: how to maximize benefit and optimize risk?. Mediastinum 3, 35 (2019).","journal-title":"Mediastinum"},{"key":"30970_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.21037\/med-21-47","volume":"7","author":"E Pietroluongo","year":"2023","unstructured":"Pietroluongo, E. et al. Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemic. Mediastinum 7, 8 (2023).","journal-title":"Mediastinum"},{"key":"30970_CR8","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jtho.2023.06.015","volume":"18","author":"E Pietroluongo","year":"2023","unstructured":"Pietroluongo, E. et al. Impaired seroconversion after severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with thymic epithelial tumors. J. Thorac. Oncol. 18, 1399\u20131407 (2023).","journal-title":"J. Thorac. Oncol."},{"key":"30970_CR9","volume":"2","author":"M Ballman","year":"2021","unstructured":"Ballman, M. et al. Tolerability of coronavirus disease 2019 vaccines, BNT162b2 and mRNA-1273, in patients with thymic epithelial tumors. JTO Clin. Res. Rep. 2, 100229 (2021).","journal-title":"JTO Clin. Res. Rep."},{"key":"30970_CR10","doi-asserted-by":"publisher","first-page":"1233056","DOI":"10.3389\/fimmu.2023.1233056","volume":"14","author":"G Cernera","year":"2023","unstructured":"Cernera, G. et al. Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response. Front. Immunol. 14, 1233056 (2023).","journal-title":"Front. Immunol."},{"key":"30970_CR11","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1515\/cclm-2023-1283","volume":"62","author":"G Cernera","year":"2024","unstructured":"Cernera, G. et al. Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors. Clin. Chem. Lab. Med. 62, 1198\u20131205 (2024).","journal-title":"Clin. Chem. Lab. Med."},{"key":"30970_CR12","doi-asserted-by":"publisher","first-page":"9427","DOI":"10.1038\/s41598-019-45861-1","volume":"9","author":"ME Macpherson","year":"2019","unstructured":"Macpherson, M. E. et al. Impaired HDL function amplifies systemic inflammation in common variable immunodeficiency. Sci. Rep. 9, 9427 (2019).","journal-title":"Sci. Rep."},{"key":"30970_CR13","doi-asserted-by":"publisher","first-page":"1199727","DOI":"10.3389\/fimmu.2023.1199727","volume":"14","author":"SF Jorgensen","year":"2023","unstructured":"Jorgensen, S. F. et al. Disturbed lipid profile in common variable immunodeficiency\u2014A pathogenic loop of inflammation and metabolic disturbances. Front. Immunol. 14, 1199727 (2023).","journal-title":"Front. Immunol."},{"key":"30970_CR14","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1038\/s41598-021-82426-7","volume":"11","author":"M Caterino","year":"2021","unstructured":"Caterino, M. et al. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. Sci. Rep. 11, 2941 (2021).","journal-title":"Sci. Rep."},{"key":"30970_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12944-017-0594-3","volume":"16","author":"M Femlak","year":"2017","unstructured":"Femlak, M., Gluba-Brzozka, A., Cialkowska-Rysz, A. & Rysz, J. The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk. Lipids Health Dis. 16, 207 (2017).","journal-title":"Lipids Health Dis."},{"key":"30970_CR16","doi-asserted-by":"publisher","first-page":"10645","DOI":"10.3390\/ijms241310645","volume":"24","author":"CK Chang","year":"2023","unstructured":"Chang, C. K. et al. The sizes and composition of HDL-cholesterol are significantly associated with inflammation in rheumatoid arthritis patients. Int. J. Mol. Sci. 24, 10645 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"30970_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12967-025-06123-z","volume":"23","author":"A Giannattasio","year":"2025","unstructured":"Giannattasio, A. et al. Serum HDL and their subfractions are impaired in multisystem inflammatory syndrome in children (MIS-C). J. Transl. Med. 23, 99 (2025).","journal-title":"J. Transl. Med."},{"key":"30970_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","volume":"4","author":"C Herve","year":"2019","unstructured":"Herve, C., Laupeze, B., Del Giudice, G., Didierlaurent, A. M. & Tavares Da Silva, F. The how\u2019s and what\u2019s of vaccine reactogenicity. NPJ Vaccines 4, 39 (2019).","journal-title":"NPJ Vaccines"},{"key":"30970_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s13054-023-04589-1","volume":"27","author":"F Hamilton","year":"2023","unstructured":"Hamilton, F., Pedersen, K. M., Ghazal, P., Nordestgaard, B. G. & Smith, G. D. Low levels of small HDL particles predict but do not influence risk of sepsis. Crit. Care 27, 389 (2023).","journal-title":"Crit. Care"},{"key":"30970_CR20","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/cvr\/cvac194","volume":"119","author":"M Harslof","year":"2023","unstructured":"Harslof, M., Pedersen, K. M., Afzal, S., Davey Smith, G. & Nordestgaard, B. G. Lower levels of small HDL particles associated with increased infectious disease morbidity and mortality: A population-based cohort study of 30 195 individuals. Cardiovasc. Res. 119, 957\u2013968 (2023).","journal-title":"Cardiovasc. Res."},{"key":"30970_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1434","volume":"12","author":"M Severa","year":"2023","unstructured":"Severa, M. et al. A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients. Clin. Transl. Immunol. 12, e1434 (2023).","journal-title":"Clin. Transl. Immunol."},{"key":"30970_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.molmed.2022.04.007","volume":"28","author":"IP Trougakos","year":"2022","unstructured":"Trougakos, I. P. et al. Adverse effects of COVID-19 mRNA vaccines: The spike hypothesis. Trends Mol. Med. 28, 542\u2013554 (2022).","journal-title":"Trends Mol. Med."},{"key":"30970_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118355","volume":"261","author":"S Cacciapuoti","year":"2020","unstructured":"Cacciapuoti, S. et al. Immunocytometric analysis of COVID patients: A contribution to personalized therapy?. Life Sci. 261, 118355 (2020).","journal-title":"Life Sci."},{"key":"30970_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.985433","volume":"13","author":"M Gelzo","year":"2022","unstructured":"Gelzo, M. et al. MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity. Front. Immunol. 13, 985433 (2022).","journal-title":"Front. Immunol."},{"key":"30970_CR25","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/metabo12080680","volume":"12","author":"M Gelzo","year":"2022","unstructured":"Gelzo, M. et al. Biomarkers of endothelial damage in distinct phases of multisystem inflammatory syndrome in children. Metabolites 12, 680 (2022).","journal-title":"Metabolites"},{"key":"30970_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523\u2013532 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"30970_CR27","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/biomedicines9091090","volume":"9","author":"RA Ballout","year":"2021","unstructured":"Ballout, R. A. et al. The NIH lipo-COVID study: A pilot NMR investigation of lipoprotein subfractions and other metabolites in patients with severe COVID-19. Biomedicines 9, 1090 (2021).","journal-title":"Biomedicines"},{"key":"30970_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MOL.0b013e3282364a17","volume":"18","author":"BJ Ansell","year":"2007","unstructured":"Ansell, B. J., Fonarow, G. C. & Fogelman, A. M. The paradox of dysfunctional high-density lipoprotein. Curr. Opin. Lipidol. 18, 427\u2013434 (2007).","journal-title":"Curr. Opin. Lipidol."},{"key":"30970_CR29","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1097\/01.CCM.0000171183.79525.6B","volume":"33","author":"JY Chien","year":"2005","unstructured":"Chien, J. Y., Jerng, J. S., Yu, C. J. & Yang, P. C. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit. Care Med 33, 1688\u20131693 (2005).","journal-title":"Crit. Care Med"},{"key":"30970_CR30","doi-asserted-by":"publisher","first-page":"1121819","DOI":"10.3389\/fphar.2023.1121819","volume":"14","author":"R Bauer","year":"2023","unstructured":"Bauer, R., Brune, B. & Schmid, T. Cholesterol metabolism in the regulation of inflammatory responses. Front. Pharmacol. 14, 1121819 (2023).","journal-title":"Front. Pharmacol."},{"key":"30970_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.862999","volume":"9","author":"V Chidambaram","year":"2022","unstructured":"Chidambaram, V. et al. Association of lipid levels with COVID-19 infection, disease severity and mortality: A systematic review and meta-analysis. Front. Cardiovasc. Med. 9, 862999 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"30970_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coi.2018.09.002","volume":"55","author":"BE Jones","year":"2018","unstructured":"Jones, B. E., Maerz, M. D. & Buckner, J. H. IL-6: a cytokine at the crossroads of autoimmunity. Curr. Opin. Immunol. 55, 9\u201314 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"30970_CR33","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3390\/cells12111447","volume":"12","author":"P Cortese","year":"2023","unstructured":"Cortese, P. et al. The immune response to SARS-CoV-2 vaccine in a cohort of family pediatricians from southern Italy. Cells 12, 1447 (2023).","journal-title":"Cells"},{"key":"30970_CR34","unstructured":"https:\/\/www.aiom.it\/raccomandazioni-2020-su-tumori-epiteliali-del-timo-tet\/"},{"key":"30970_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11883-021-00925-4","volume":"23","author":"WS Davidson","year":"2021","unstructured":"Davidson, W. S., Cooke, A. L., Swertfeger, D. K. & Shah, A. S. The difference between high density lipoprotein subfractions and subspecies: An evolving model in cardiovascular disease and diabetes. Curr. Atheroscler. Rep. 23, 23 (2021).","journal-title":"Curr. Atheroscler. Rep."},{"key":"30970_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12967-021-03072-1","volume":"19","author":"G Scalia","year":"2021","unstructured":"Scalia, G. et al. Cytometric analysis of patients with COVID-19: What is changed in the second wave?. J. Transl. Med. 19, 403 (2021).","journal-title":"J. Transl. Med."},{"key":"30970_CR37","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.3390\/jcm11154306","volume":"11","author":"G Scalia","year":"2022","unstructured":"Scalia, G. et al. Lymphocyte population changes at two time points during the acute period of COVID-19 infection. J. Clin. Med. 11, 4306 (2022).","journal-title":"J. Clin. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30970-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30970-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30970-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:03:28Z","timestamp":1768345408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30970-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30970"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30970-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the University Federico II of Naples (#76.21). Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"1618"}}